A new mindset for public sector leadership
Take the #TenYearChallenge
Government and public services have changed substantially in the past decade and so have the demands on public sector leaders. This article sets out the new capabilities that the sector’s leaders need today – and the new mindset they will need to thrive in the future.
2021 global life sciences outlook
Possibility is now reality, sustaining forward momentum
Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger. How will life sciences companies continue to respond and what areas can they build resiliency going forward?
The future awakens
Life Sciences and Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.
Breaking the dependency cycle
How health inequalities of vulnerable families can be tackled in Western Europe
Despite rising life expectancy across Western Europe, vulnerable families face significant health inequalities. This report from the Deloitte UK Centre for Health Solutions warns of the damaging consequences of health inequality.
Time to care
Securing a future for the hospital workforce in Europe
In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.
The digital hospital of the future
In 10 years, technology may change the face of global health care delivery
Learn how the digital hospital of the future can leverage technology to transform the future of health care delivery, including digital patient experience in this report developed by Deloitte US.